News

The consolidation of the two charities is based on their joint commitment to accelerate and fund biomedical research into the causes, prevention, treatments and cure for autism spectrum

Arformoterol tartrate is a long-acting beta-agonist formulation for long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the US according to

Symadex was found to produce remyelination (repair of damaged myelin) in the study even after 40 days of inflammatory insult by preventing the infiltration of autoreactive cells into

The top line results show that none of the 36 patients enrolled in the study had a recurrence of liver function abnormalities that resulted in discontinuation of ambrisentan

Acrux describes what has been dubbed the ‘spay-on pill’, as a fourth-generation progestin contraceptive that has no androgenic hormonal effects, and a good safety profile. It says it

Under the terms of the agreement, Forest will make a $50 million upfront payment to Replidyne as well as potential future milestone payments. In addition, Replidyne will receive

In January 2005, CytRx announced the filing of a clinical protocol with the FDA to allow amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) patients who have completed

The approvals are for American Pharmaceutical Partners’ (APP) abbreviated new drug applications (ANDAs) for octreotide acetate injection, single-dose and multiple dose vials. Octreotide acetate injection is indicated for

QR-435 has demonstrated antiviral activity against ocular and genital herpes in preclinical studies at a US university, indicating a new R&D path for the versatile antiviral compound. Quigley